228 related articles for article (PubMed ID: 3274584)
1. HLA-DP matching in allogeneic bone marrow transplantation.
Pawelec G; Ehninger G; Schmidt H; Rehbein A; Balko I; Wernet P
Transplant Proc; 1987 Feb; 19(1 Pt 3):2741-3. PubMed ID: 3274584
[No Abstract] [Full Text] [Related]
2. HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantation.
Pawelec G; Ehninger G; Schmidt H; Wernet P
Transplantation; 1986 Nov; 42(5):558-60. PubMed ID: 3538541
[No Abstract] [Full Text] [Related]
3. HLA-DP and allogeneic bone marrow transplantation.
Moreau P; Cesbron A
Bone Marrow Transplant; 1994 Jun; 13(6):675-81. PubMed ID: 7920290
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
[No Abstract] [Full Text] [Related]
5. Allogeneic bone marrow transplantation using unrelated marrow donors.
Fay JW; Collins RH; Piñeiro L
Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
[No Abstract] [Full Text] [Related]
6. Allogeneic bone marrow transplantation at Christchurch 1979-1985.
Heslop HE; Heaton DC; Hart DN; Allen JR; Abbott GD; Beard ME
N Z Med J; 1986 May; 99(801):318-21. PubMed ID: 3520412
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases.
Gluckman E; Devergie A; Marty M; Bussel A; Rottemboúrg J; Dausset J; Bernard J
Transplant Proc; 1978 Mar; 10(1):141-5. PubMed ID: 345552
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood chemiluminescence as an early indicator of successful bone marrow transplantation.
Toivanen A; Nikoskelainen J; Lilius EM; Salmi TT; Kätkä K; Pelliniemi TT; Mäki AL; Rajamäki A
Transplant Proc; 1987 Feb; 19(1 Pt 3):2745-6. PubMed ID: 3079095
[No Abstract] [Full Text] [Related]
9. BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment.
Ladenstein R; Peters C; Matthes-Martin S; Rosenmayr A; Höcker P; Pötter R; Pötschinger U; Gadner H
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():86-91. PubMed ID: 8932806
[No Abstract] [Full Text] [Related]
10. Herpes virus immunity and acute graft-versus-host disease.
Gratama JW; Weiland HT; Hekker AC; Weijers TF; The TH; Stijnen T; Zwaan FE; Vossen JM
Transplant Proc; 1987 Feb; 19(1 Pt 3):2680-2. PubMed ID: 2856285
[No Abstract] [Full Text] [Related]
11. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical significance of HLA-DP patient-donor mismatches in allogeneic bone marrow transplantation.
Howell WM; Sage DA; Kohler JA; Darke C; Taylor GM
Bone Marrow Transplant; 1995 May; 15(5):816-7. PubMed ID: 7670416
[No Abstract] [Full Text] [Related]
13. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
15. Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Petersdorf EW; Smith AG; Mickelson EM; Longton GM; Anasetti C; Choo SY; Martin PJ; Hansen JA
Transplant Proc; 1993 Feb; 25(1 Pt 2):1230-1. PubMed ID: 8442097
[No Abstract] [Full Text] [Related]
16. Marrow transplantation in aplastic anemia.
Storb R; Buckner CD; Fefer A; Clift RA; Neiman PE; Gluksberg H; Lerner KG; Thomas ED
Transplant Proc; 1974 Dec; 6(4):355-8. PubMed ID: 4612891
[No Abstract] [Full Text] [Related]
17. Less acute GVHD in patients receiving totally matched transplants from unrelated donors.
Lönnqvist B; Ljungman P; Norrby M; Olerup O; Ringdén O; Winiarski J
Transplant Proc; 1995 Dec; 27(6):3528-9. PubMed ID: 8540084
[No Abstract] [Full Text] [Related]
18. Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
Hägglund H; Boström L; Ringdén O; Nilsson B; Remberger M
Transplant Proc; 1994 Jun; 26(3):1821-2. PubMed ID: 8030154
[No Abstract] [Full Text] [Related]
19. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
[TBL] [Abstract][Full Text] [Related]
20. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
